GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
2 246,00 ₹
arrow_downward
-0,85%(-19,30) 1D
14 қаз., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
2 275,00 ₹
High
2 286,40 ₹
Low
2 242,00 ₹
Mkt. cap
633,49 млрд
Avg. vol.
576,02 м.
Volume
257,94 м.
Dividend
0,22%
Quarterly dividend
1,25 ₹
Ex-dividend date
2025 ж. 03 қаз.
P/E ratio
35,27
52-wk high
2 537,60 ₹
52-wk low
1 792,60 ₹
EPS
63,68 ₹
Shares outstanding
0,00
No. of employees
17 мың
Open
2 275,00 ₹
High
2 286,40 ₹
Low
2 242,00 ₹
Mkt. cap
633,49 млрд
Avg. vol.
576,02 м.
Volume
257,94 м.
Dividend
0,22%
Quarterly dividend
1,25 ₹
Ex-dividend date
2025 ж. 03 қаз.
P/E ratio
35,27
52-wk high
2 537,60 ₹
52-wk low
1 792,60 ₹
EPS
63,68 ₹
Shares outstanding
0,00
No. of employees
17 мың
News stories
From web sources and news partners
Simply Wall Street
·
21 минут бұрын
Palo Alto Networks (PANW) Becomes Founding Partner In Critical Infrastructure Defense Program
TradingView
·
1 сағат бұрын
Versus Systems (NASDAQ: VS) Leadership Highlights Drinkfinger Expansion and AI Approach in Stock2Me Podcast
AP News
·
35 минут бұрын
Inflation worsened last month to 3.7% in sign that prices remain elevated as midterm elections near
The Arkansas Democrat-Gazette
·
45 минут бұрын
Little Rock based BSR Real Estate Investment Trust shares trading on the New York Stock Exchange
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd